KBLB logo.jpg
Kraig Biocraft Laboratories Announces Investor Web Conference Highlighting Commercialization Progress of Spider Silk Technologies
December 03, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) will broadcast its investor web conference on 12/4/24 4:30 pm ET, at www.kraiglabs.com/videos or on the Company's YouTube channel
KBLB logo.jpg
Kraig Biocraft Laboratories Announces Successful Completion of Latest Recombinant Spider Silk Production Batch
November 04, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) successfully completed its fourth 2024 production cycle, with record-setting performance across nearly every tracked metric
KBLB logo.jpg
Kraig Biocraft Laboratories Launches Spider Silk Production at Recently Completed Higher Capacity Facility
September 23, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) begins first BAM-1 parental strains production at its new production center with capacity to support 25 tons of spider silk
logo-neoVolta-black-ticker-rTM-600x136.png
NeoVolta Selected as Strategic Partner with Barrio Eléctrico for Growth in Puerto Rico as part of $21M Award
September 17, 2024 08:45 ET | NeoVolta Inc.
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: NEOV), NeoVolta Inc., a leading provider of advanced energy storage solutions, has been selected as a strategic partner with Barrio Eléctrico...
Dr. Nirmal Kumar Assessing Automatic Silk Reeling Facilities.jpg
Kraig Biocraft Laboratories Significantly Increases Spider Silk Reeling Efficiency, Boosting Per Cocoon Yield
August 26, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) further boosts spider silk production with the introduction of new silk cocoon reeling protocols resulting in higher silk yields
Rani-Logo.jpg
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering
July 22, 2024 08:30 ET | Rani Therapeutics, LLC
SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
KBLB logo.jpg
Kraig Biocraft Laboratories Completes Phase One of its Spider Silk Production Facility Expansion
July 15, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) completed the first phase of construction for its production facility expansion to support the Company's third production wave
KBLB logo.jpg
Kraig Biocraft Laboratories Increases Spider Silk Production with Next Generation of Hybrid Eggs Completed
June 25, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) expanded its production of spider silk with the creation of the next generation of BAM-1 hybrid
KBLB logo.jpg
Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production
June 03, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) is now in production with its BAM-1 spider silk hybrids, following the resounding successes of its spring production trials
inmunebio.jpg
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 25, 2024 09:00 ET | INmune Bio, Inc.
Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) --  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...